Beneficient current report, 21 March 2024

Beneficient Form 8-K Summary

Business Context and Reporting Period

Beneficient filed a Current Report on Form 8-K dated March 21, 2024, reporting the results of its Special Meeting of Stockholders held that day. The filing concerns corporate governance and capital structure actions, not periodic financial results.

Financial and Operating Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance metrics.

  • Shares represented at the meeting: 208,184,532 Class A shares and 19,140,451 Class B shares.
  • Voting participation represented approximately 88.9% of total voting power as of the February 29, 2024 record date.

Material Changes and Voting Results

  • Reverse stock split approved: Stockholders approved a reverse split of the outstanding common stock at a ratio ranging from 1-for-10 to 1-for-100.
  • The exact ratio, effective date, and timing remain subject to the Board of Directors’ discretion.
  • A simultaneous proportionate reduction in the authorized shares of each class of common stock was also approved.
  • Proposal 1 vote: 399,526,380 for, 56,662 against, and 6,000 abstaining.
  • Meeting adjournment approved: Stockholders approved adjournment, if necessary, to permit additional proxy solicitation or voting related to Proposal 1.
  • Proposal 2 vote: 399,544,823 for, 30,795 against, and 13,424 abstaining.

Outlook, Risks, and Unusual Items

The reverse split is authorized but was not stated to have been implemented as of the filing. Investors should note that the final split ratio and effective date have not been specified in the filing and could materially affect the number of shares outstanding and the per-share trading price. The filing provides no financial guidance or management discussion of operating performance.

Key Facts for Investors to Verify

  • Whether the Board elects to implement the reverse split.
  • The final ratio selected within the 1-for-10 to 1-for-100 range.
  • The effective date and resulting number of shares outstanding and authorized shares.
  • Any subsequent Nasdaq or SEC filings regarding implementation and trading adjustments.